Galmed Pharmaceuticals (GLMD) Invested Capital (2013 - 2026)
Galmed Pharmaceuticals (GLMD) posted quarterly Invested Capital of $355000.0 for Q1 2026, down 28.86% year-over-year from $499000.0 in Q1 2025, and down 57.84% quarter-over-quarter from $842000.0 in Q4 2025.
Galmed Pharmaceuticals (GLMD) Invested Capital (2013 - 2026) Analysis & Trends
Galmed Pharmaceuticals' Invested Capital history runs 14 years deep, the most recent figure standing at $355000.0 for Q1 2026.
- In Q1 2026, Invested Capital fell 28.86% year-over-year to $355000.0; the TTM figure through Mar 2026 stood at $3.0 million (up 22.81% YoY), while the FY2025 annual figure was $842000.0, up 83.44% from the prior year.
- Invested Capital for Q1 2026 stood at $355000.0, down from $842000.0 in the prior quarter.
- The five-year high for Invested Capital was $1.2 million in Q3 2024, with the low at $351000.0 in Q2 2024.
- The 5-year median for Invested Capital is $600000.0 (2023), against an average of $656375.0.
- The sharpest annual moves came in 2022 and 2025: Invested Capital sank 53.59% in 2022, then jumped 199.72% in 2025.
- Galmed Pharmaceuticals' Invested Capital stood at $534000.0 in 2022, then soared by 63.11% to $871000.0 in 2023, then sank by 47.3% to $459000.0 in 2024, then jumped by 83.44% to $842000.0 in 2025, then slumped by 57.84% to $355000.0 in 2026.
- Business Quant data shows GLMD's Invested Capital at $355000.0 in Q1 2026, $842000.0 in Q4 2025, and $798000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Galmed Pharmaceuticals | 2.31 Mn | -9.57 Mn | - | 355,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,000.00 |
| Dec 31, 2025 | 842,000.00 |
| Sep 30, 2025 | 798,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 499,000.00 |
| Dec 31, 2024 | 459,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 351,000.00 |
| Mar 31, 2024 | 382,000.00 |
| Dec 31, 2023 | 871,000.00 |
| Sep 30, 2023 | 617,000.00 |
| Jun 30, 2023 | 583,000.00 |
| Mar 31, 2023 | 535,000.00 |
| Dec 31, 2022 | 534,000.00 |
| Jun 30, 2022 | 640,000.00 |
| Mar 31, 2022 | 812,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 1.38 Mn |
| Mar 31, 2021 | 1.33 Mn |